Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin

Thangirala Sudha; Murat Yalcin; Hung Yun Lin; Ahmed M. Elmetwally; Tipu Nazeer; Thiruvengadam Arumugam; Patricia Phillips; Shaker A. Mousa

doi:10.1016/j.canlet.2014.04.016

Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin

Thangirala Sudha, Murat Yalcin, Hung Yun Lin, Ahmed M. Elmetwally, Tipu Nazeer, Thiruvengadam Arumugam, Patricia Phillips, Shaker A. Mousa

研究成果: 雜誌貢獻 › 文章 › 同行評審

27 引文斯高帕斯（Scopus）

摘要

Sulfated non-anticoagulant heparins (S-NACHs) might be preferred for potential clinical use in cancer patients without affecting hemostasis as compared to low molecular weight heparins (LMWHs). We investigated anti-tumor effects, anti-angiogenesis effects, and mechanisms of S-NACH in a mouse model of pancreatic cancer as compared to the LMWH tinzaparin. S-NACH or tinzaparin with or without gemcitabine were administered, and tumor luminescent signal intensity, tumor weight, and histopathology were assessed at the termination of the study. S-NACH and LMWH efficiently inhibited tumor growth and metastasis, without any observed bleeding events with S-NACH as compared to tinzaparin. S-NACH distinctly increased tumor necrosis and enhanced gemcitabine response in the mouse pancreatic cancer models. These data suggest the potential implication of S-NACH as a neoadjuvant in pancreatic cancer.

原文	英語
頁（從 - 到）	25-33
頁數	9
期刊	Cancer Letters
卷	350
發行號	1-2
DOIs	https://doi.org/10.1016/j.canlet.2014.04.016
出版狀態	已發佈 - 8月 1 2014

ASJC Scopus subject areas

腫瘤科
癌症研究

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1016/j.canlet.2014.04.016

其它文件與鏈接

Link to publication in Scopus

引用此

@article{aaa08a5899344cf28f9a90d5a131952d,

title = "Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin",

abstract = "Sulfated non-anticoagulant heparins (S-NACHs) might be preferred for potential clinical use in cancer patients without affecting hemostasis as compared to low molecular weight heparins (LMWHs). We investigated anti-tumor effects, anti-angiogenesis effects, and mechanisms of S-NACH in a mouse model of pancreatic cancer as compared to the LMWH tinzaparin. S-NACH or tinzaparin with or without gemcitabine were administered, and tumor luminescent signal intensity, tumor weight, and histopathology were assessed at the termination of the study. S-NACH and LMWH efficiently inhibited tumor growth and metastasis, without any observed bleeding events with S-NACH as compared to tinzaparin. S-NACH distinctly increased tumor necrosis and enhanced gemcitabine response in the mouse pancreatic cancer models. These data suggest the potential implication of S-NACH as a neoadjuvant in pancreatic cancer.",

keywords = "Anti-cancer, Low molecular weight heparin, Non-anticoagulant heparin, Pancreatic cancer, Tumor suppressor, Tumor survival",

author = "Thangirala Sudha and Murat Yalcin and Lin, {Hung Yun} and Elmetwally, {Ahmed M.} and Tipu Nazeer and Thiruvengadam Arumugam and Patricia Phillips and Mousa, {Shaker A.}",

note = "Funding Information: This work was supported by the National Institutes of Health (Grant Number 1R21CA124931-01 to S.A.M.). We appreciate the excellent editing by Dr. Kelly A. Keating, Pharmaceutical Research Institute (PRI) and the technical support by members of the PRI.",

year = "2014",

month = aug,

day = "1",

doi = "10.1016/j.canlet.2014.04.016",

language = "English",

volume = "350",

pages = "25--33",

journal = "Cancer Letters",

issn = "0304-3835",

publisher = "Elsevier Ireland Ltd",

number = "1-2",

}

TY - JOUR

T1 - Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin

AU - Sudha, Thangirala

AU - Yalcin, Murat

AU - Lin, Hung Yun

AU - Elmetwally, Ahmed M.

AU - Nazeer, Tipu

AU - Arumugam, Thiruvengadam

AU - Phillips, Patricia

AU - Mousa, Shaker A.

N1 - Funding Information: This work was supported by the National Institutes of Health (Grant Number 1R21CA124931-01 to S.A.M.). We appreciate the excellent editing by Dr. Kelly A. Keating, Pharmaceutical Research Institute (PRI) and the technical support by members of the PRI.

PY - 2014/8/1

Y1 - 2014/8/1

N2 - Sulfated non-anticoagulant heparins (S-NACHs) might be preferred for potential clinical use in cancer patients without affecting hemostasis as compared to low molecular weight heparins (LMWHs). We investigated anti-tumor effects, anti-angiogenesis effects, and mechanisms of S-NACH in a mouse model of pancreatic cancer as compared to the LMWH tinzaparin. S-NACH or tinzaparin with or without gemcitabine were administered, and tumor luminescent signal intensity, tumor weight, and histopathology were assessed at the termination of the study. S-NACH and LMWH efficiently inhibited tumor growth and metastasis, without any observed bleeding events with S-NACH as compared to tinzaparin. S-NACH distinctly increased tumor necrosis and enhanced gemcitabine response in the mouse pancreatic cancer models. These data suggest the potential implication of S-NACH as a neoadjuvant in pancreatic cancer.

AB - Sulfated non-anticoagulant heparins (S-NACHs) might be preferred for potential clinical use in cancer patients without affecting hemostasis as compared to low molecular weight heparins (LMWHs). We investigated anti-tumor effects, anti-angiogenesis effects, and mechanisms of S-NACH in a mouse model of pancreatic cancer as compared to the LMWH tinzaparin. S-NACH or tinzaparin with or without gemcitabine were administered, and tumor luminescent signal intensity, tumor weight, and histopathology were assessed at the termination of the study. S-NACH and LMWH efficiently inhibited tumor growth and metastasis, without any observed bleeding events with S-NACH as compared to tinzaparin. S-NACH distinctly increased tumor necrosis and enhanced gemcitabine response in the mouse pancreatic cancer models. These data suggest the potential implication of S-NACH as a neoadjuvant in pancreatic cancer.

KW - Anti-cancer

KW - Low molecular weight heparin

KW - Non-anticoagulant heparin

KW - Pancreatic cancer

KW - Tumor suppressor

KW - Tumor survival

UR - http://www.scopus.com/inward/record.url?scp=84901494319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901494319&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2014.04.016

DO - 10.1016/j.canlet.2014.04.016

M3 - Article

C2 - 24769074

AN - SCOPUS:84901494319

SN - 0304-3835

VL - 350

SP - 25

EP - 33

JO - Cancer Letters

JF - Cancer Letters

IS - 1-2

ER -

Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin

摘要

ASJC Scopus subject areas

UN SDG

存取文件

其它文件與鏈接

指紋

引用此